外科理论与实践 ›› 2019, Vol. 24 ›› Issue (05): 395-399.doi: 10.16139/j.1007-9610.2019.05.006
蔡钢, 谢金容, 陈佳艺
收稿日期:
2019-09-11
出版日期:
2019-10-05
发布日期:
2019-10-05
通讯作者:
陈佳艺,E-mail: chenjiayi0188@aliyun.com
Received:
2019-09-11
Online:
2019-10-05
Published:
2019-10-05
中图分类号:
蔡钢, 谢金容, 陈佳艺. 早期乳腺癌的术后放射治疗研究[J]. 外科理论与实践, 2019, 24(05): 395-399.
[1] Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet,2011,378(9804):1707-1716. [2] START Trialists' Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial[J]. Lancet Oncol,2008,9(4):331-341. [3] Whelan TJ, Pignol JP, Levine MN, et al.Long-term results of hypofractionated radiation therapy for breast cancer[J]. N Engl J Med,2010,362(6):513-520. [4] Smith BD, Bentzen SM, Correa CR, et al.Fractionation for whole breast irradiation: an American Society for Radiation Oncology(ASTRO) Evidence-Based Guideline[J]. Int J Radiat Oncol Biol Phys.2011,81(1):59-68. [5] Haviland JS, Owen JR, Dewar JA, et al.The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol,2013,14(11):1086-1094. [6] Smith BD, Bellon JR, Blitzblau R, et al.Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology(ASTRO) evidence-based guideline[J]. Pract Radiat Oncol,2018,8(3):145-152. [7] Strnad V, Ott OJ, Hildebrandt G, et al.5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial[J]. Lancet,2016,387(10015):229-238. [8] Correa C, Harris EE, Leonardi MC, et al.Accelerated partial breast irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement[J]. Pract Radiat Oncol,2017,7(2):73-79. [9] EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials[J]. Lancet,2014,383(9935):2127-2135. [10] Poortmans PM, Collette S, Kirkove C, et al.Internal mammary and medial supraclavicular irradiation in breast cancer[J]. N Engl J Med,2015,373(4):317-327. [11] Whelan TJ, Olivotto IA, Parulekar WR, et al.Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med,2015,373(4):307-316. [12] Thorsen LB, Offersen BV, Danø H, et al.DBCG-IMN: A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J]. J Clin Oncol,2016,34(4):314-320. [13] Wang SL, Fang H, Song YW, et al.Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial[J]. Lancet Oncol,2019,20(3):352-360. [14] NCCN. Clinical Practice Guidelines in Oncology-Breast Cancer(2016 Version 1)[DB/OL]. 2015-11-18[2019-09-11].http://www.nccn.org. [15] Hughes KS, Schnaper LA, Bellon JR, et al.Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343[J]. J Clin Oncol,2013,31(19):2382-2387. [16] Kunkler IH, Williams LJ, Jack WJL, et al.Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial[J]. Lancet Oncol,2015,16(3):266-273. [17] Solin LJ, Gray R, Hughes LL, et al.Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 Study[J]. J Clin Oncol,2015,33(33):3938-3944. [18] Panchal H, Matros E.Current trends in postmastectomy breast reconstruction[J]. Plast Reconstr Surg,2017,140(5S Advances in Breast Reconstruction): 7S-13S. [19] 修秉虬, 郭瑢, 杨犇龙, 等. 中国乳腺癌术后乳房重建手术横断面调查研究[J]. 中华肿瘤杂志,2019,41(7): 546-551. [20] Jagsi R, Momoh AO, Qi J, et al.Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction[J]. J Natl Cancer Inst,2018,110(2). doi: 10.1093/jnci/djx148. [21] Vargo JA, Beriwal S.RTOG Chest Wall Contouring Guidelines for post-mastectomy radiation therapy: Is it evidence-based?[J]. Int J Radiat Oncol Biol Phys,2015,93(2):266-267. [22] Offersen BV, Boersma LJ, Kirkove C, et al.ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer[J]. Radiother Oncol,2015,114(1):3-10. [23] Nissen HD, Yates ES, Andersen K, et al.PO-0918: Consensus on target volume delineation and treatment planning strategy for the DBCG RT Recon trial[J]. Radiother Oncol,2018,127:S492-S494. [24] Kaidar-Person O, Vrou Offersen B, Hol S, et al.ESTRO ACROP consensus guideline for target volume delinea-tion in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer[J]. Radiother Oncol,2019,137:159-166. |
[1] | 祝旭龙 刘鑫淼 吴姝涵 李建辉. 适用于乳房组织工程的支架材料及制备工艺[J]. 组织工程与重建外科杂志, 2022, 18(5): 413-. |
[2] | 姚成才 陈明 刘长春 黄传蔷 冼家仪 严国标 陈庞洲. 硅凝胶乳房假体联合钛网补片在早期乳腺癌即刻乳房重建中的应用[J]. 组织工程与重建外科杂志, 2022, 18(3): 247-. |
[3] | 吴佳毅, 陆裕杰, 何金光, 沈坤炜, 徐华. 乳腺癌术后植入物乳房重建技术[J]. 外科理论与实践, 2022, 27(05): 387-391. |
[4] | 陈诗锐 徐媛 顾军 袁斯明. 背阔肌肌皮瓣联合假体在乳腺癌改良根治术后即刻乳房重建中的应用 [J]. 组织工程与重建外科杂志, 2021, 17(5): 394-. |
[5] | 鲍婉婷, 曹丽辰, 魏昊, 余力, 周广东, 郭善禹. PGS构建特定形状脂肪组织的可行性研究[J]. 组织工程与重建外科杂志, 2020, 16(2): 87-90. |
[6] | 吴可, 修秉虬, 郭瑢, 张琪, 李伦, 杨犇龙, 王嘉, 苏永辉, 季玮儒, 邵鼎轶, 邵志敏, 吴炅. 中国乳腺癌乳房重建改型手术的横断面调查[J]. 外科理论与实践, 2020, 25(05): 426-431. |
[7] | 吴可, 吴炅. 乳腺癌术后乳房重建的并发症及其危险因素[J]. 外科理论与实践, 2020, 25(02): 163-166. |
[8] | 田宝星,潘赟昊,曹丽辰,鲍婉婷,赵峰,徐华,冯少青,章一新,郭善禹. 乳腺癌根治术后一期乳房重建10年随访分析[J]. 组织工程与重建外科杂志, 2019, 15(3): 168-170. |
[9] | 徐华. 乳腺癌术后自体组织乳房重建的现况[J]. 外科理论与实践, 2019, 24(05): 391-394. |
[10] | 金贻婷, 储呈玉, 张薇, 富丽娜, 汤伟军, 董佳生, 徐华, 邹强. CTA预选胸廓内动脉肋间穿支为腹壁下动脉穿支皮瓣乳房重建的受区血管[J]. 外科理论与实践, 2019, 24(04): 330-336. |
[11] | 郑丹宁, 李青峰,. 乳腺癌术后畸形和乳房重建整形术[J]. 外科理论与实践, 2017, 22(05): 393-396. |
[12] | 曹旭晨,. 肌肉在乳房重建手术中的意义[J]. 外科理论与实践, 2017, 22(05): 376-379. |
[13] | 施勇, 温涛, 黄凯明, 王科, 郑晶燕, 李校堃,. 胸外侧动脉穿支前锯肌筋膜瓣修复乳房缺损[J]. 外科理论与实践, 2017, 22(02): 157-161. |
[14] | 吴敏,任玉萍,徐逸,侯楷,随文文,王宁宁,吴毅平. 基于假体和生物膜的乳房重建技术的临床应用研究[J]. 组织工程与重建外科杂志, 2015, 11(2): 64-66. |
[15] | 胡学庆,包祺,姜方震,邵哲人,王建伟. 吲哚菁绿血管造影在乳腺癌术后乳房重建中的应用[J]. 组织工程与重建外科杂志, 2015, 11(2): 87-89. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||